European therapeutic trials in ANCA-associated systemic vasculitis: Disease scoring, consensus regimens and proposed clinical trials EUROPEAN COMMUNITY STUDY GROUP ON CLINICAL TRIALS IN SYSTEMIC VASCULITIS ECSYSVASTRIAL (BMHl-Cr93-1078)

Eitemau Tebyg

• Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
  gan: Suppiah, R, et al.
  Cyhoeddwyd: (2011)
• Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials
  gan: Suppiah, R, et al.
  Cyhoeddwyd: (2011)
• Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
  gan: De Groot, K, et al.
  Cyhoeddwyd: (2005)
• Randomized trial of cyclophosphamide versus methotrexate for induction of remission in "non-renal" AbCA-associated vasculitis.
  gan: de Groot, K, et al.
  Cyhoeddwyd: (2003)
• EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
  gan: Hellmich, B, et al.
  Cyhoeddwyd: (2007)